$RDW: Full transcript of my latest conversation with Peter Cannito, Chairman & CEO of Redwire, is now available.
In my view, Q2 2026 was Redwire's strongest quarter to date, and this conversation explains exactly why.
It's well worth the read. https://t.co/vWNhRNlIE7
What Does This Have to Do With Space?
You've all seen this morning's Merck–Moderna announcement.
The melanoma results are about combining Keytruda with a personalized cancer vaccine, training the immune system to recognize the specific mutations in a patient's tumor.
Part of Keytruda's formulation research happened aboard the International Space Station.
Space did not make Keytruda better at killing cancer but it gave scientists something almost impossible to create on Earth, a laboratory where gravity don't interfere with crystal growth.
Microgravity might have helped reveal a better way to handle one of the world’s most important cancer medicines.